Hydrocortisone Sodium Phosphate

4 trials 3 recruiting SOphthalmology & ENT

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

3 Recruiting

1 Completed trials

4 Sponsors

20 Countries

Phase III

Phase II/III

Phase III/IV

Phase IV

Phase III: 1 Phase II/III: 1 Phase III/IV: 1 Phase IV: 1

Oversight events:

3 serious breaches 4 temporary halts across 2 trials

View oversight register →

Indications tested

Dry eye 1 Meibomian gland dysfunction 1 Epidermolysis bullosa 1

Sponsors using this IMP

Centre Hospitalier Universitaire De Nantes 1 Karolinska University Hospital 1 Laboratorios Lesvi S.L. 1 Rheacell GmbH & Co. KG 1

All trials

4 total

Phase III clinical trial of ABCB5+ MSCs for the treatment of EB Recruiting

2022-500266-10-00 Phase III 12 countries Rheacell GmbH & Co. KG
Comparison of topical hydrocortisone versus dexamethasone treatment for inflammatory secretions of the conjunctiva in patients with ocular p… Recruiting

2024-517441-14-00 Phase III/IV 1 country Centre Hospitalier Universitaire De Rennes
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Recruiting

2022-501050-11-01 Phase II/III 14 countries Karolinska University Hospital
Evaluation of the efficacy and safety of topical treatment on clinical signs and symptoms of dry eye disease associated with moderate meibom… Ended

2024-518093-13-00 Phase IV 1 country Laboratorios Thea S.A.

Showing 1–4 of 4 trials

← All drugs A–Z